Licences of 18 pharma firms cancelled for manufacturing spurious drugs
2023-03-28
[ad_1] New Delhi: In a major crackdown against the manufacture of substandard drugs, central and state regulators conducted joint inspections at 76 pharma companies and cancelled the licences of 18 of them for producing spurious and adulterated drugs, official sources said on Tuesday. The inspections were carried out across 20Continue Reading
